Die letzten wichtigen Nachrichten zum Thema PRESS RELEASE
Do 10.11.2022
Statistik
Quelle: FinanzNachrichten.de vom Do 10.11.2022 16:41 COVID 19
Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission First and only next-generation protein-based adjuvanted COVID-19 booster approved in Eu... Nachricht lesen...
Quelle: FinanzNachrichten.de vom Do 10.11.2022 16:41 COVID 19Sanofi - Aventis Groupe: Press Release: Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission
Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission First and only next-generation protein-based adjuvanted COVID-19 booster approved in Eu... Nachricht lesen...
Fr 07.01.2022
Statistik
Quelle: finanzen.net vom Fr 07.01.2022 07:14 Release
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, January 07, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced ... Nachricht lesen...
Quelle: finanzen.net vom Fr 07.01.2022 07:14 ReleasePress Release: Strong Cresemba(R) (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, January 07, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced ... Nachricht lesen...
Mi 22.12.2021
Statistik Quelle: finanzen.net vom Mi 22.12.2021 07:59 Novartis
-- There are no currently approved therapies impacting disease progression for the up to 8 million people suffering from geographic atrophy (GA)1,2 -- Acquisition will add GT005 to the Novartis portfolio, an investigational, one-time ... Nachricht lesen...
Quelle: finanzen.net vom Mi 22.12.2021 07:59 NovartisPress Release: Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause o...
-- There are no currently approved therapies impacting disease progression for the up to 8 million people suffering from geographic atrophy (GA)1,2 -- Acquisition will add GT005 to the Novartis portfolio, an investigational, one-time ... Nachricht lesen...
Mo 20.12.2021
Statistik Quelle: finanzen.net vom Mo 20.12.2021 12:14 Release
forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines ... Nachricht lesen...
Quelle: finanzen.net vom Mo 20.12.2021 12:14 ReleasePress Release: Novartis strengthens immunotherapy -2
forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines ... Nachricht lesen...
Mi 15.12.2021
Statistik Quelle: finanzen.net vom Mi 15.12.2021 13:16 Release
Pratteln, Switzerland, December 15, 2021 -- Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting (EGM) held today at the Company's domicile in ... Nachricht lesen...
Quelle: finanzen.net vom Mi 15.12.2021 13:16 ReleasePress Release: Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Meeting
Pratteln, Switzerland, December 15, 2021 -- Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting (EGM) held today at the Company's domicile in ... Nachricht lesen...
Fr 10.12.2021
Statistik Quelle: finanzen.net vom Fr 10.12.2021 13:59 Novartis
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," ... Nachricht lesen...
Quelle: finanzen.net vom Fr 10.12.2021 13:59 NovartisPress Release: Novartis data highlight efficacy -2
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," ... Nachricht lesen...
Do 04.11.2021
Statistik Quelle: finanzen.net vom Do 04.11.2021 14:59 Novartis
Adakveo Characterization of Two Anti-P-Selectin Monoclonal Abstract presentation #2032 (crizanlizumab) Antibodies (mAbs): Crizanlizumab Shows Comparable Poster available: or Stronger Effects Versus Inclacumab Across Cell Sunday, December ... Nachricht lesen...
Quelle: finanzen.net vom Do 04.11.2021 14:59 NovartisPress Release: New data at ASH spotlight Novartis -2
Adakveo Characterization of Two Anti-P-Selectin Monoclonal Abstract presentation #2032 (crizanlizumab) Antibodies (mAbs): Crizanlizumab Shows Comparable Poster available: or Stronger Effects Versus Inclacumab Across Cell Sunday, December ... Nachricht lesen...
Fr 22.10.2021
Statistik Quelle: finanzen.net vom Fr 22.10.2021 04:59 SIKA ON TRACK TO
NET SALES BY REGION 1.1.2020 1.1.2021 - - Year-on-year change in CHF mn 30.9.2020 30.9.2021 (+/- in %) -------------- --------- --------- -------------------------------------------------------- In local Currency Acquisition Organic ... Nachricht lesen...
Quelle: finanzen.net vom Fr 22.10.2021 04:59 SIKA ON TRACK TOPress Release: SIKA ON TRACK TO SET RECORDS AFTER -2
NET SALES BY REGION 1.1.2020 1.1.2021 - - Year-on-year change in CHF mn 30.9.2020 30.9.2021 (+/- in %) -------------- --------- --------- -------------------------------------------------------- In local Currency Acquisition Organic ... Nachricht lesen...
Di 19.10.2021
Statistik Quelle: finanzen.net vom Di 19.10.2021 07:14 Global
As a leading global medicines company, we use innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research ... Nachricht lesen...
Quelle: finanzen.net vom Di 19.10.2021 07:14 GlobalPress Release: Global Heart Hub and Novartis -2
As a leading global medicines company, we use innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research ... Nachricht lesen...
Mo 20.09.2021
Statistik Quelle: finanzen.net vom Mo 20.09.2021 18:09 Group
Nachricht lesen...
Quelle: finanzen.net vom Mo 20.09.2021 18:09 GroupPress Release Relating to the Filing of the Draft Note Prepared by Europcar Mobility Group in Response to the Public Tender Offer Initiated by Green Mobility Holding S.A.
Nachricht lesen...
Do 19.08.2021
Statistik Quelle: finanzen.net vom Do 19.08.2021 22:29 IRW PRESS
SIKA TO DIVEST EUROPEAN INDUSTRIAL COATINGS BUSINESS Sika has agreed to sell its European industrial coatings business, based in Germany, to The Sherwin-Williams Company, the US-based global leader in paints and coatings. In 2020, the business segment ... Nachricht lesen...
Quelle: finanzen.net vom Do 19.08.2021 22:29 IRW PRESSPress Release: SIKA TO DIVEST EUROPEAN INDUSTRIAL COATINGS BUSINESS
SIKA TO DIVEST EUROPEAN INDUSTRIAL COATINGS BUSINESS Sika has agreed to sell its European industrial coatings business, based in Germany, to The Sherwin-Williams Company, the US-based global leader in paints and coatings. In 2020, the business segment ... Nachricht lesen...
Di 17.08.2021
Statistik Quelle: finanzen.net vom Di 17.08.2021 07:14 Press
The webcast, along with presentation will be available online https://www.globenewswire.com/Tracker?data=M5T8lNCe6Kjpf1WVE8ulZg0GOQFU4g9rECsX3WAiNWCWAElXHS2ds6QHJRr43udPzBRrkhvwzf52a9NeSzq8bMwN-nv2-a5ABFISs2LnRGutCMUY1JAssbOVWj3nz91RWlhfglmFwZ5OqsGdlyqtpA== ... Nachricht lesen...
Quelle: finanzen.net vom Di 17.08.2021 07:14 PressPress Release: Basilea reports strong financial -3
The webcast, along with presentation will be available online https://www.globenewswire.com/Tracker?data=M5T8lNCe6Kjpf1WVE8ulZg0GOQFU4g9rECsX3WAiNWCWAElXHS2ds6QHJRr43udPzBRrkhvwzf52a9NeSzq8bMwN-nv2-a5ABFISs2LnRGutCMUY1JAssbOVWj3nz91RWlhfglmFwZ5OqsGdlyqtpA== ... Nachricht lesen...
Do 03.06.2021
Statistik Quelle: finanzen.net vom Do 03.06.2021 23:04 IRW PRESS
Novartis Media Relations E-mail: media.relations@novartis.com Anja von Treskow Rachel Levine Novartis External Communications Advanced Accelerator Applications, a Novartis Company +41 79 392 8697 +1 917 375 2935 ... Nachricht lesen...
Quelle: finanzen.net vom Do 03.06.2021 23:04 IRW PRESSPress Release: Novartis reports clinically -3
Novartis Media Relations E-mail: media.relations@novartis.com Anja von Treskow Rachel Levine Novartis External Communications Advanced Accelerator Applications, a Novartis Company +41 79 392 8697 +1 917 375 2935 ... Nachricht lesen...
Mi 02.06.2021
Statistik Quelle: finanzen.net vom Mi 02.06.2021 07:14 Novartis
Novartis around the world. Find out more at https://www.novartis.com. Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews For Novartis multimedia content, please visit https://www.novartis.com/news/media-library ... Nachricht lesen...
Quelle: finanzen.net vom Mi 02.06.2021 07:14 NovartisPress Release: Novartis presents positive Phase -2
Novartis around the world. Find out more at https://www.novartis.com. Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews For Novartis multimedia content, please visit https://www.novartis.com/news/media-library ... Nachricht lesen...
Mi 19.05.2021
Statistik Quelle: finanzen.net vom Mi 19.05.2021 22:59 IRW PRESS
those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling ... Nachricht lesen...
Quelle: finanzen.net vom Mi 19.05.2021 22:59 IRW PRESSPress Release: Novartis to unveil new data at -2
those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling ... Nachricht lesen...
Mi 28.04.2021
Statistik Quelle: finanzen.net vom Mi 28.04.2021 00:59 IRW PRESS
SIKA ACQUIRES LEADING ADHESIVES AND SEALANTS BUSINESS IN JAPAN Sika has agreed to acquire Hamatite, the adhesives business of The Yokohama Rubber Co., Ltd. Hamatite is a market leader in Japan, offering adhesives and sealants to the ... Nachricht lesen...
Quelle: finanzen.net vom Mi 28.04.2021 00:59 IRW PRESSPress Release: SIKA ACQUIRES LEADING ADHESIVES AND SEALANTS BUSINESS IN JAPAN
SIKA ACQUIRES LEADING ADHESIVES AND SEALANTS BUSINESS IN JAPAN Sika has agreed to acquire Hamatite, the adhesives business of The Yokohama Rubber Co., Ltd. Hamatite is a market leader in Japan, offering adhesives and sealants to the ... Nachricht lesen...
Do 08.04.2021
Statistik Quelle: finanzen.net vom Do 08.04.2021 06:59 IRW PRESS
Geneva, Switzerland, April 8, 2021 -- Addex Therapeutics https://www.globenewswire.com/Tracker?data=PnB3_q7SnocXwhKbpoq8zJYKEbD03MIh59wc9iNFrQ6YeY3liMNY-UsXKQBQPbmF2ONxDotoqG0x-CMC4eVDJtgloPnR0y5OjZLfxRLqnvk= Ltd (SIX: ADXN and Nasdaq: ... Nachricht lesen...
Quelle: finanzen.net vom Do 08.04.2021 06:59 IRW PRESSPress Release: Addex Files Registration Statement on Form F-3 with the US Securities and Exchange Commission
Geneva, Switzerland, April 8, 2021 -- Addex Therapeutics https://www.globenewswire.com/Tracker?data=PnB3_q7SnocXwhKbpoq8zJYKEbD03MIh59wc9iNFrQ6YeY3liMNY-UsXKQBQPbmF2ONxDotoqG0x-CMC4eVDJtgloPnR0y5OjZLfxRLqnvk= Ltd (SIX: ADXN and Nasdaq: ... Nachricht lesen...
Do 01.04.2021
Statistik Quelle: finanzen.net vom Do 01.04.2021 07:24 IRW PRESS
Basel, Switzerland, April 01, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing of the previously announced divestment of its Chinese research and development (RD) subsidiary Basilea Pharmaceutica China ... Nachricht lesen...
Quelle: finanzen.net vom Do 01.04.2021 07:24 IRW PRESSPress Release: Basilea announces closing of previously announced transaction regarding divestment of its Chinese R&D subsidiary
Basel, Switzerland, April 01, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing of the previously announced divestment of its Chinese research and development (RD) subsidiary Basilea Pharmaceutica China ... Nachricht lesen...
Di 23.03.2021
Statistik Quelle: finanzen.net vom Di 23.03.2021 07:14 Novartis
4. Hupe MC, Philippi C, Roth D, et al. Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis. Front Oncol 2018;8:623. 5. Sant ... Nachricht lesen...
Quelle: finanzen.net vom Di 23.03.2021 07:14 NovartisPress Release: Novartis announces positive result -2
4. Hupe MC, Philippi C, Roth D, et al. Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis. Front Oncol 2018;8:623. 5. Sant ... Nachricht lesen...
Di 23.02.2021
Statistik Quelle: finanzen.net vom Di 23.02.2021 17:47 IRW PRESS
NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL Basel, Switzerland, February 23, 2021 Basilea Pharmaceutica Ltd ("Basilea" ... Nachricht lesen...
Quelle: finanzen.net vom Di 23.02.2021 17:47 IRW PRESSPress Release: Basilea launches a private placement of new shares by way of an accelerated bookbuilding
NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL Basel, Switzerland, February 23, 2021 Basilea Pharmaceutica Ltd ("Basilea" ... Nachricht lesen...
Fr 19.02.2021
Statistik Quelle: finanzen.net vom Fr 19.02.2021 04:59 PROFIT AND CASH
CONTINUATION OF SUCCESSFUL GROWTH STRATEGY AND OUTLOOK Despite the coronavirus crisis and its repercussions for operating results, Sika is confirming its 2023 strategic targets. The company remains aligned for long-term success and ... Nachricht lesen...
Quelle: finanzen.net vom Fr 19.02.2021 04:59 PROFIT AND CASHPress Release: RECORD RESULTS FOR PROFIT AND CASH -2
CONTINUATION OF SUCCESSFUL GROWTH STRATEGY AND OUTLOOK Despite the coronavirus crisis and its repercussions for operating results, Sika is confirming its 2023 strategic targets. The company remains aligned for long-term success and ... Nachricht lesen...
Mi 17.02.2021
Statistik Quelle: finanzen.net vom Mi 17.02.2021 03:29 IRW PRESS
This press release is also available in Français (pdf) https://www.globenewswire.com/Tracker?data=qMmIs1TlwcE8LrEED58t2hIkuLTeEMplcJ3J64ZONV1PjJY3M1O3OWByYZ-DXix_IF1jepKlW4gse1ncIzE8pcrY1gjCFS_B5WAWF2CutgEXguAeyBFwiX2RLbp1mprYLjH8OJ-1ivMz2G-BZVxatbMeGCHerlji-A2QDSr-W7j-8lb_5Ib-ZGuoLC3ZhBCci4MW0v15OI7SWFRAEzTmpQ== ... Nachricht lesen...
Quelle: finanzen.net vom Mi 17.02.2021 03:29 IRW PRESSPress Release: Nestle: Nestlé continues strategic transformation of water business, agrees on sale of Nestlé Waters North America brands
This press release is also available in Français (pdf) https://www.globenewswire.com/Tracker?data=qMmIs1TlwcE8LrEED58t2hIkuLTeEMplcJ3J64ZONV1PjJY3M1O3OWByYZ-DXix_IF1jepKlW4gse1ncIzE8pcrY1gjCFS_B5WAWF2CutgEXguAeyBFwiX2RLbp1mprYLjH8OJ-1ivMz2G-BZVxatbMeGCHerlji-A2QDSr-W7j-8lb_5Ib-ZGuoLC3ZhBCci4MW0v15OI7SWFRAEzTmpQ== ... Nachricht lesen...
Di 16.02.2021
Statistik Quelle: finanzen.net vom Di 16.02.2021 19:22
Circulation. 2020;141:e139-e596. doi:10.1161/CIR.0000000000000757 5. Solomon S, Rizkala A, Gong J, et al. Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF ... Nachricht lesen...
Quelle: finanzen.net vom Di 16.02.2021 19:22Press Release: Novartis Entresto(R) granted -2
Circulation. 2020;141:e139-e596. doi:10.1161/CIR.0000000000000757 5. Solomon S, Rizkala A, Gong J, et al. Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF ... Nachricht lesen...
Do 11.02.2021
Statistik Quelle: finanzen.net vom Do 11.02.2021 07:14 PRESS Reyna Silver
Basel, Switzerland, February 11, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has promoted a potential first-in-class small-molecule kinase inhibitor from its research portfolio into the next preclinical development ... Nachricht lesen...
Quelle: finanzen.net vom Do 11.02.2021 07:14 PRESS Reyna SilverPress Release: Basilea achieves preclinical milestone in oncology collaboration on potential first-in-class kinase inhibitor
Basel, Switzerland, February 11, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has promoted a potential first-in-class small-molecule kinase inhibitor from its research portfolio into the next preclinical development ... Nachricht lesen...
Do 07.01.2021
Statistik Quelle: finanzen.net vom Do 07.01.2021 02:59 Global
Geneva, Switzerland, January 7, 2021 -- Addex Therapeutics https://www.globenewswire.com/Tracker?data=-nnhK0OWLYxJEB1RJjGOquKhGvo-Kf0L54A7t-n7eZgN1-tWMwgWleEWo-X6av5L4HacU5QvNHQh_5LNgCNw7TctSFGxZiVRTReuzm-JTUY= Ltd (SIX: ADXN and Nasdaq: ... Nachricht lesen...
Quelle: finanzen.net vom Do 07.01.2021 02:59 GlobalPress Release: Addex Announces Pricing of $10.0 Million Global Offering
Geneva, Switzerland, January 7, 2021 -- Addex Therapeutics https://www.globenewswire.com/Tracker?data=-nnhK0OWLYxJEB1RJjGOquKhGvo-Kf0L54A7t-n7eZgN1-tWMwgWleEWo-X6av5L4HacU5QvNHQh_5LNgCNw7TctSFGxZiVRTReuzm-JTUY= Ltd (SIX: ADXN and Nasdaq: ... Nachricht lesen...
Fr 18.12.2020
Statistik Quelle: finanzen.net vom Fr 18.12.2020 22:49 Novartis
E-mail: investor.relations@novartis.com Central North America Samir Shah +41 61 324 7944 Sloan Simpson +1 862 778 5052 Thomas Hungerbuehler +41 61 324 8425 Isabella Zinck +41 61 324 7188 (END) Dow Jones Newswires December 18, 2020 16:50 ... Nachricht lesen...
Quelle: finanzen.net vom Fr 18.12.2020 22:49 NovartisPress Release: Novartis receives complete -2
E-mail: investor.relations@novartis.com Central North America Samir Shah +41 61 324 7944 Sloan Simpson +1 862 778 5052 Thomas Hungerbuehler +41 61 324 8425 Isabella Zinck +41 61 324 7188 (END) Dow Jones Newswires December 18, 2020 16:50 ... Nachricht lesen...
Mi 16.12.2020
Statistik Quelle: finanzen.net vom Mi 16.12.2020 01:17 IRW PRESS
Novartis around the world. Find out more at https://www.novartis.com. Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews For Novartis multimedia content, please visit https://www.novartis.com/news/media-library ... Nachricht lesen...
Quelle: finanzen.net vom Mi 16.12.2020 01:17 IRW PRESSPress Release: Novartis announces positive FDA -2
Novartis around the world. Find out more at https://www.novartis.com. Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews For Novartis multimedia content, please visit https://www.novartis.com/news/media-library ... Nachricht lesen...
Fr 06.07.2012
Statistik Quelle: finanzen.net vom Fr 06.07.2012 00:00
Quelle: finanzen.net vom Fr 06.07.2012 00:00 PRESS RELEASE: Shareholders of Private Equity Holding approve all proposals by the Board of Directors by a large majority
Nachricht lesen...Mo 02.07.2012
Statistik Quelle: finanzen.net vom Mo 02.07.2012 00:15
Quelle: finanzen.net vom Mo 02.07.2012 00:15 PRESS RELEASE: Thomson Reuters ONE Ad-hoc/Ad-hoc-announcement according to section 15 WpHG: Linde intends to acquire Lincare Holdings Inc., Clearwater, Flori...
Nachricht lesen...Fr 08.06.2012
Statistik Quelle: finanzen.net vom Fr 08.06.2012 09:55
Quelle: finanzen.net vom Fr 08.06.2012 09:55